These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6464668)

  • 1. Reduced binding of 3H-spiroperidol to lymphocyte in Wilson's disease.
    Członkowski A; Członkowska A
    Acta Neurol Scand; 1984 May; 69(5):298-301. PubMed ID: 6464668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrease in lymphocyte [3H]spiroperidol binding sites in Parkinsonism.
    Le Fur G; Meininger V; Phan T; Gérard A; Baulac M; Uzan A
    Life Sci; 1980 Oct; 27(17):1587-91. PubMed ID: 7442460
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymphocyte 3H-spiroperidol binding in schizophrenia: preliminary findings.
    Rotstein E; Mishra RK; Singal DP; Barone D
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):729-32. PubMed ID: 6686701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]spiperone binding to lymphocyte in extrapyramidal disease and in aging.
    Członkowska A; Jachowicz-Jeszka J; Członkowski A
    Brain Behav Immun; 1987 Sep; 1(3):197-203. PubMed ID: 2975511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dopaminergic receptors on lymphocytes in idiopathic Parkinson's disease (author's transl)].
    Le Fur G; Meininger V; Baulac M; Phan T; Uzan A
    Rev Neurol (Paris); 1981; 137(2):89-96. PubMed ID: 7244495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocytes of healthy subjects and schizophrenic patients possess no high-affinity binding sites for spiroperidol.
    Rao ML; Deister A; Roth A
    Pharmacopsychiatry; 1990 Jul; 23(4):176-81. PubMed ID: 2381986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3H-spiperone binding in platelet membranes: a possible biological marker for schizophrenia.
    Sethi BB; Kumar P; Agarwal AK; Seth PK; Trivedi JK
    Acta Psychiatr Scand; 1986 Feb; 73(2):186-90. PubMed ID: 3705995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of dopamine agonist and antagonist binding sites in mammalian retina.
    Makman MH; Dvorkin B; Horowitz SG; Thal LJ
    Brain Res; 1980 Aug; 194(2):403-18. PubMed ID: 6770965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
    Neve KA; Altar CA; Wong CA; Marshall JF
    Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of stereospecific [3H]spiroperidol binding sites in mammalian lymphocytes.
    Le Fur G; Phan T; Uzan A
    Life Sci; 1980 Apr; 26(14):1139-48. PubMed ID: 7392792
    [No Abstract]   [Full Text] [Related]  

  • 11. 3H-spiroperidol binding sites in blood platelets.
    Khanna AS; Agrawal AK; Seth PK
    Biochem Biophys Res Commun; 1987 Aug; 146(3):983-8. PubMed ID: 3619946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA; Marsh CL
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]-Spiroperidol labels dopamine receptors in membranes from rabbit mesenteric artery.
    Brodde OE; Gross G
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Apr; 311(3):249-54. PubMed ID: 7393340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3H]spiroperidol binding on lymphocytes: changes in two different groups of schizophrenic patients and effect of neuroleptic treatment.
    Le Fur G; Zarifian E; Phan T; Cuche H; Flamier A; Bouchami F; Burgevin MC; Loo H; Gérard A; Uzan A
    Life Sci; 1983 Jan; 32(3):249-55. PubMed ID: 6130459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3H-Spiroperidol labels dopamine receptors in pituitary and brain.
    Creese I; Schneider R; Snyder SH
    Eur J Pharmacol; 1977 Dec; 46(4):377-81. PubMed ID: 590345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine receptor sensitivity after chronic dopamine agonists. Striatal 3H-spiroperidol binding in mice after chronic administration of high doses of apomorphine, N-n-propylnorapomorphine and dextroamphetamine.
    Riffee WH; Wilcox RE; Vaughn DM; Smith RV
    Psychopharmacology (Berl); 1982; 77(2):146-9. PubMed ID: 6812131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3H-spiperone binding sites in lymphocytes as possible vulnerability marker in schizophrenia.
    Bondy B; Ackenheil M
    J Psychiatr Res; 1987; 21(4):521-9. PubMed ID: 3481637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3H-spiroperidol binding sites in the rabbit superior mesenteric artery. A histoautoradiographic study.
    Amenta F; Cavallotti C; De Rossi M; Sancesario G; Gerli R
    Pharmacology; 1984; 28(2):104-11. PubMed ID: 6424145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relation between brain D2-dopamine receptors and 3H-spiperone binding sites of intact lymphocytes].
    Noguchi-kuno SA; Nakata C; Nishitani H
    Rinsho Shinkeigaku; 1983 Sep; 23(9):814-8. PubMed ID: 6232031
    [No Abstract]   [Full Text] [Related]  

  • 20. [3H]Spiroperidol binding to a putative dopaminergic receptor in rat pituitary gland.
    Stefanini E; Devoto P; Marchisio AM; Vernaleone F; Collu R
    Life Sci; 1980 Feb; 26(8):583-7. PubMed ID: 7382736
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.